AquaBounty seeks Canadian approval for biotech salmon

AquaBounty Technologies has taken the initial steps to seek approval in Canada for its biotech salmon as it awaits an FDA panel's review of the product. AquaBounty President and CEO Ronald Stotish said the Canadian application is in its early stages, but the company is "very interested because of our strong presence" in the country.

View Full Article in:

Gazette (Montreal) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX